Who is AxoGen?
AxoGen, Inc. is a regenerative medicine company focused on the development and commercialization of technologies for peripheral nerve reconstruction and regeneration. The Company has created and licensed a unique combination of patented technologies and has a rich pipeline of new products to change the standard of care for patients with peripheral nerve injuries.
What products does AxoGen offer?
Avance® Nerve Graft is the first commercially available allograft nerve for bridging nerve discontinuities. AxoGuard® Nerve Connector is a coaptation aid allowing for close approximation of severed nerves. AxoGuard® Nerve Protector is a protective wrap used in cases of nerves damaged by compression, or to protect and isolate nerves during the healing process.
Where can I find more information about AxoGen and its technologies?
For additional information, please visit our website at www.axogeninc.com.
How does AxoGen plan to maintain a competitive advantage in the peripheral nerve graft market?
AxoGen provides a patent protected product suite that addresses the surgical peripheral nerve continuum. Avance® Nerve Graft is a product used in nerve reconstruction where the gap between the nerve ends is typically greater than 5mm. AxoGen developed the Avance® Nerve Graft by following the guiding principle that the human body created the optimal nerve structure. Processed from recovered human peripheral nerve tissue, Avance® Nerve Graft provides the natural nerve structure of an autograft nerve but with the ease and availability of an off-the-shelf product.
AxoGuard® Nerve Protector minimizes the potential for soft tissue attachments and nerve entrapment by physically isolating the nerve during the healing process.
AxoGuard® Nerve Connector is for gaps between the nerve ends up to 5mm and provides a coaptation aid for the reconstruction.
Both AxoGuard® Nerve Protector and AxoGuard® Nerve Connector provide the unique features of pliability, suturability, and translucence for visualization of the underlying nerve while allowing the patient's own cells to incorporate into the extracellular matrix to remodel and form a tissue similar to the nerve epineurium.
Through R&D, licensing or acquisition, AxoGen will also continue to expand its product offering with products that Bring the Science of Nerve Repair to Life
What is the AxoGen ticker symbol and on what exchange does it trade?
AxoGen is registered on the Over-The-Counter Bulletin Board (OTCBB) under the ticker symbol "AXGN".
How do I buy stock in AxoGen?
In order to invest in AxoGen, please contact a licensed stockbroker to purchase shares of AxoGen, Inc. ("AXGN").
How do I contact AxoGen's transfer agent? AxoGen's transfer agent is Wells Fargo:
By U.S. Mail:
Wells Fargo Shareowner Services
P.O. Box 64874
St. Paul, MN 55164-0874
By Other Carriers:
Wells Fargo Shareowner Services
161 North Concord Exchange
South St. Paul, MN 55075
Phone: 1-800-401-1957
Online: https://www.wellsfargo.com/com/shareowner_services/
Email: https://www.wellsfargo.com/com/shareowner_services/contact
How do I report a change of contact information on my account?
In order to keep you updated on noteworthy AxoGen news, please advise our transfer agent of any changes to your contact information. You may also visit www.axogeninc.com for up-to-date news and information on the company.
When is AxoGen’s next earnings release?
Earnings press release and conference call/webcast dates and times are listed in Events. A copy of all press releases and replays of investor events are posted on the website under AxoGen News. To be notified of AxoGen News and upcoming investor events, please complete the signup form located on our Email Alerts page.
Does AxoGen pay a dividend and when will it be paid?
AxoGen does not pay a dividend at this time. Future dividends will be determinied by the Board of Directors.
How do I get a copy of the company’s financial statements, such as an Annual Report, SEC filings?
Annual Reports, SEC filings, and financial statements are available for viewing on this website and can also be downloaded or printed. To sign up to be notified when the Annual Report or latest SEC filing is available, please visit the Investor Data section of the Investors page.
How do I contact AxoGen Investor Relations?
Investor Relations
AxoGen, Inc.
13859 Progress Blvd.
Suite 100
Alachua, FL 32615
Email: InvestorRelations@AxoGenInc.com
Customer Service: 888-AXOGEN1 (888-296-4361)
Fax: 386-462-6801 (Fax)
|
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||
